About this trial
The aim of this study is to compare the efficacy of magnesium sulphate, ondansetron, and dexmedetomidine in managing post-spinal anesthesia shivering. The primary aim is the time to cessation of shivering after drug administration, while secondary aim include hemodynamic parameters (heart rate, blood pressure, SpO₂ ) and the recurrence of shivering
Eligibility criteria
Qualifiers
Age from 18 to 45 years.
Both sexes.
American Society of Anesthesiologists physical status I, II
Scheduled for elective lower abdominal or lower limb surgeries under spinal anesthesia
Disqualifiers
Patients with known allergy to study drugs.
Patients with baseline body temperature outside the normal range (36-37.5°C).
History of thermoregulatory disorders, thyroid dysfunction, or neurological diseases.
Patients receive sedatives, antipsychotics, or antidepressants.
Trial design
Treatments tested in this trial
- Dexmedetomidin
- Mg (magnesium sulfate)
- Ondansetron 8 mg